Tirzepatide 10-30mgCertificate of Analysis: May_2025 Certificate of Analysis: July_2024 Tirzepatide is a novel investigational medicine developed by Eli Lilly and Company for the treatment of type 2 diabetes. It belongs to a class of medications called dual glucose dependent insulinotropic peptide (GIP) and glucagon like peptide 1 (GLP 1) receptor agonists. This means it targets two different hormones involved in blood sugar regulation. Clinical trials have shown
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols